SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Eid
Lv6
3010 积分
2021-08-30 加入
最近求助
最近应助
互助留言
Isatuximab plus carfilzomib–dexamethasone versus carfilzomib–dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial
10天前
已完结
EHA2024 Hybrid Congress
13天前
已完结
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
17天前
已完结
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
17天前
已关闭
Personalized therapy guided by single‐cell transcriptomic analysis in relapsed and refractory KMT2A::MLLT10AML with extensive extramedullary infiltration: A case report
18天前
已完结
Acute myeloid leukaemia
18天前
已完结
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
1个月前
已完结
First Versus Second Generation Bruton Tyrosine Kinase Inhibitors in Waldenström's Macroglobulinemia: A Systematic Review and Meta‐analysis
1个月前
已完结
Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis
1个月前
已完结
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma
1个月前
已完结
没有进行任何应助
抱歉,我要的2023版的哈,不是2019版的 不好意思,辛苦啦
1个月前
速度真快,感谢,点赞
1个月前
点赞
1个月前
感谢
1个月前
速度真快,帮大忙了
3个月前
感谢,感谢,点赞
5个月前
自行 获取【积分已退回】
8个月前
发错内容了【积分已退回】
8个月前
点赞,感谢,速度真快,帮大忙了,么么哒
1年前
点赞
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论